Kerala Ayurveda (BOM:530163) Beta: 1.4756 (As of Jun. 29, 2026)


BOM:530163 Kerala Ayurveda Ltd BOM:530163
47 GF Score
Price ₹187.10
GF Value ₹318.38
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Kerala Ayurveda Beta?

Kerala Ayurveda BOM:530163 +0.70% 47 Beta is 1.4756 as of Jun. 29, 2026. GuruFocus rates BOM:530163 with a GF Score™ of 47/100 and a GF Value™ of ₹318.38 (Possible Value Trap). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-29), Kerala Ayurveda's Beta is 1.4756.


Kerala Ayurveda  (BOM:530163) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Kerala Ayurveda Beta Related Terms


Kerala Ayurveda Beta Historical Data

* Premium members only.

The historical data trend for Kerala Ayurveda's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kerala Ayurveda Beta Chart

Kerala Ayurveda Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.91 0.87 0.27 0.35 1.23

Kerala Ayurveda Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.22 0.52 0.58 1.23

BOM:530163 vs ZTS, UTHR: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kerala Ayurveda's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kerala Ayurveda Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kerala Ayurveda's Beta distribution charts can be found below:

* The bar in red indicates where Kerala Ayurveda's Beta falls into.


BOM:530163
47GF Score
Kerala Ayurveda Ltd BOM:530163
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kerala Ayurveda Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.4756 mean?
Kerala Ayurveda (BOM:530163) has a Beta of 1.4756 as of Jun. 29, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Kerala Ayurveda and its competitors.
Is Kerala Ayurveda's Beta too high?
Kerala Ayurveda's current Beta is 1.4756. Overall, Kerala Ayurveda has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kerala Ayurveda's Beta compare to ZTS and UTHR?
Kerala Ayurveda's Beta of 1.4756 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Kerala Ayurveda and its competitors. Kerala Ayurveda's current Beta is 1.4756. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kerala Ayurveda stock overvalued right now?
Based on GuruFocus' analysis, Kerala Ayurveda (BOM:530163) is currently considered Possible Value Trap. The stock's GF Value™ is ₹318.38, compared to a current price of ₹187.10 — trading 41.2% below its estimated fair value. The current Beta is 1.4756. Kerala Ayurveda's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Kerala Ayurveda (BOM:530163), the current Beta is 1.4756 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kerala Ayurveda (BOM:530163) Overvalued in 2026?

Based on GuruFocus' analysis, Kerala Ayurveda stock appears to be undervalued. The current stock price of ₹187.10 is trading 41.2% below its estimated GF Value™ of ₹318.38. GuruFocus considers Kerala Ayurveda to be Possible Value Trap.

Key valuation signals for BOM:530163:

  • Beta: 1.4756
  • GF Value™: ₹318.38 vs. price of ₹187.10 (41.2% below fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the BOM:530163 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kerala Ayurveda Business Description

Address XV/551, Athani Post, Nedumbassery, Ernakulam District, Ernakulam, KL, IND, 683585
Kerala Ayurveda Ltd is engaged in producing and selling ayurvedic products and providing healthcare services. The company offers ayurvedic medicine products for diabetes and heart health, skin and hair care, kids' health, women's care, men's care, gastro care, respiratory and allergy, general healthcare, massage oils, renal care, and joint care. It provides services through wellness clinics, resorts, hospitals, and academies. The company has only one reportable business segment, i.e., Full-spectrum Ayurvedic wellness. It generates maximum revenue from the sale of products. Geographically, the company generates maximum revenue from its business in India and also has some exposure to other markets.
47GF Score

Get the complete analysis for BOM:530163

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹187.10
Price
₹318.38
GF Value